Jon P. Stonehouse
2013
In 2013, Jon P. Stonehouse earned a total compensation of $2M as President, Chief Executive Officer and Director at BioCryst Pharmaceuticals, a 59% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $166,501 |
|---|---|
| Option Awards | $1,230,523 |
| Salary | $475,716 |
| Stock Awards | $88,892 |
| Other | $13,655 |
| Total | $1,975,287 |
Stonehouse received $1.2M in option awards, accounting for 62% of the total pay in 2013.
Stonehouse also received $166.5K in non-equity incentive plan, $475.7K in salary, $88.9K in stock awards and $13.7K in other compensation.
Rankings
In 2013, Jon P. Stonehouse's compensation ranked 3,940th out of 12,286 executives tracked by ExecPay. In other words, Stonehouse earned more than 67.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,940 out of 12,286 | 68th |
Division Manufacturing | 1,330 out of 4,612 | 71st |
Major group Chemicals And Allied Products | 360 out of 1,462 | 75th |
Industry group Drugs | 252 out of 1,156 | 78th |
Industry Biological Products, Except Diagnostic Substances | 36 out of 196 | 82nd |
Source: SEC filing on April 11, 2016.
Stonehouse's colleagues
We found four more compensation records of executives who worked with Jon P. Stonehouse at BioCryst Pharmaceuticals in 2013.